Pharmala Biotech Holdings Inc. (CSE:MDMA)

Market Cap	17.59M
Revenue	n/a
Net Income	n/a
Shares Out	103.45M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,706
Average Volume	84,503
Open	0.1750
Previous Close	0.1800
Day's Range	0.1600 - 0.1750
52-Week Range	0.0650 - 0.3400
Beta	1.27
RSI	40.14
Earnings Date	n/a

About Pharmala Biotech Holdings

Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredient under the LaNeo brand name. The company is headquartered in Vancouver, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Nicholas Kadysh
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: MDMA